Sengenics Successfully Produces Functional COVID-19 Antigens and Makes Them Available for Research and Vaccine Development

Sengenics, a leading precision medicine company, today announced that the company has made full-length, correctly folded and functional COVID-19 antigens available for purchase for both research and vaccine development purposes. Sengenics has successfully expressed these antigens using the company’s patented and validated KREX™technology. ”The surge of COVID-19 infections has pushed us to accelerate the production […]